Quick Takeaways
- FEDERATED HERMES, INC. filed SCHEDULE 13D for Minerva Neurosciences, Inc. Common Stock (NERV).
- Disclosed ownership: 19%.
- Date of event: 21 Oct 2025.
FEDERATED HERMES, INC. - 21 Oct 2025 SCHEDULE 13D Report for Minerva Neurosciences, Inc. Common Stock (NERV)
- Filing Manager
- FEDERATED HERMES, INC.
- Reporting Manager
- Federated Hermes, Inc.
- Symbol
- NERV
- Shares outstanding
- 6,994,177 shares
- Disclosed Ownership
- 1,351,275 shares
- Ownership
- 19%
- Form type
- SCHEDULE 13D
- Filing time
- 28 Oct 2025, 16:39:46 UTC
- Date of event
- 21 Oct 2025
- Next filing
- 29 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FEDERATED HERMES, INC. disclosed 19% ownership in Minerva Neurosciences, Inc. Common Stock (NERV) on 21 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Oct 2025, 16:39.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Federated Hermes, Inc. | 19% | 1,351,275 | 1,351,275 | 0 | /s/J. Christopher Donahue | J. Christopher Donahue, as President of Federated Hermes, Inc. | 0001056288 |
| Voting Shares Irrevocable Trust | 19% | 1,351,275 | 1,351,275 | 0 | /s/Thomas R. Donahue | Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust | |
| Thomas R. Donahue | 19% | 1,351,275 | 0 | 1,351,275 | /s/Thomas R. Donahue | Thomas R. Donahue | |
| Ann C. Donahue | 19% | 1,351,275 | 0 | 1,351,275 | /s/Ann C. Donahue | Ann C. Donahue | |
| J. Christopher Donahue | 19% | 1,351,275 | 0 | 1,351,275 | /s/J. Christopher Donahue | J. Christopher Donahue |